Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Background

Detection of M-type phospholipase A2 receptor (PLA2R) can be used in serologic diagnosis of idiopathic membranous nephropathy (IMN), but there are limited data about the sensitivity and specificity of its diagnostic values.

Methods and results

Meta-analysis of diagnostic test studies assessing the values of PLA2R in diagnosis of IMN. MEDLINE, EMBASE, and CENTRAL databases and congress abstracts were searched for studies reporting the value of PLA2R to predict IMN. The quality of the studies was evaluated using the guidelines of the updated Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. The results are summarized as sensitivity, specificity, and diagnostic odds ratio (OR). Data from 10 studies involving 1,550 participants were analyzed. Across all settings, the diagnostic OR for serum anti-PLA2R level to predict IMN at different stages was 247.41, with sensitivity of 0.69 and specificity of 0.99. The estimated sensitivity and specificity of serum anti-PLA2R level for diagnosis of IMN in the active stage were 74.0 and 95.0 %, respectively, with diagnostic OR of 54.22. The estimated sensitivity and specificity of biopsy anti-PLA2R for diagnosis of IMN at different stages was 73.0 and 83.0 %, respectively, with diagnostic OR of 13.75.

Conclusions

This meta-analysis shows that serum anti-PLA2R level is of diagnostic value for IMN in the active stage. Future large-cohort prospective studies are required to reveal the diagnostic value of circulating anti-PLA2R antibodies versus PLA2R antigens in kidney biopsy for IMN at different stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Glassock RJ (2010) The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 56(1):157–167

    Article  PubMed  Google Scholar 

  2. Segal PE, Choi MJ (2012) Recent advances and prognosis in idiopathic membranous nephropathy. Adv Chronic kidney Dis. 19(2):114–119

    Article  PubMed  Google Scholar 

  3. Ronco P, Debiec H (2005) Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 16(5):1205–1213

    Article  CAS  PubMed  Google Scholar 

  4. Waldman M, Austin HA 3rd (2009) Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol. 5(8):469–479

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Ohara O, Ishizaki J, Arita H (1995) Structure and function of phospholipase A2 receptor. Prog Lipid Res 34(2):117–138

    Article  CAS  PubMed  Google Scholar 

  6. Ishizaki J, Hanasaki K, Higashino K et al (1994) Molecular cloning of pancreatic group I phospholipase A2 receptor. J Biol Chem 269(8):5897–5904

    CAS  PubMed  Google Scholar 

  7. Hanasaki K, Arita H (2002) Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat 68–69:71–82

    Article  PubMed  Google Scholar 

  8. Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361(1):11–21

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Whiting P, Rutjes AWS, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536

    Article  PubMed  Google Scholar 

  10. Hoxha E, Harendza S, Zahner G et al (2011) An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26(8):2526–2532

    Article  CAS  PubMed  Google Scholar 

  11. Qin W, Beck LH Jr, Zeng C et al (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22(6):1137–1143

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. McGettigan B, Bundell C, Webb-Smith E, Hollingsworth P (2012) Anti-phospholipase A2 receptor antibodies-an evaluation of the clinical utility of a transfected cell based indirect immunofluorescence assay in the diagnosis of idiopathic membranous nephropathy. Intern Med J 42(Suppl 4):11

    Google Scholar 

  13. Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H (2012) Kidney biopsy is a sensitive tool for ret of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 28(7):1839–1844

    Article  PubMed  Google Scholar 

  14. Behnert A, Fritzler MJ, Teng B et al (2013) An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor. PLoS ONE 8(4):e61669

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Kanigicherla D, Gummadova J, McKenzie EA et al (2013) Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 83(5):940–948

    Article  CAS  PubMed  Google Scholar 

  16. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD (2013) Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 26(5):709–715

    Article  CAS  PubMed  Google Scholar 

  17. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS (2013) Autoantibodies against phospholipase A2 receptor in korean patients with membranous nephropathy. PLoS ONE 8(4):e62151

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Hofstra JM, Debiec H, Short CD et al (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23(10):1735–1743

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Granata F, Petraroli A, Boilard E et al (2005) Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor. J Immunol. 174(1):464–474

    CAS  PubMed  Google Scholar 

  20. Silliman CC, Moore EE, Zallen G et al (2002) Presence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesion. Am J Physiol Cell Physiol 283(4):C1102–C1113

    Article  CAS  PubMed  Google Scholar 

  21. Beck LH Jr, Fervenza FC, Beck DM et al (2011) Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22(8):1543–1550

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travels and new roads ahead. Kidney Int 77(9):765–770

    Article  CAS  PubMed  Google Scholar 

  23. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 6(6):1286–1291

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Debiec H, Ronco P (2011) PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 364(7):689–690

    Article  CAS  PubMed  Google Scholar 

  25. Prunotto M, Carnevali ML, Candiano G et al (2010) Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 21(3):507–519

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Bruschi M, Carnevali ML, Murtas C et al (2011) Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J Proteomics. 74(10):2008–2017

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest or relevant disclosures.

Author information

Authors and Affiliations

  1. Division of Nephrology, The First Hospital of JingZhou, Yangtze University, Hangkongstreet 8, Jingzhou, 434000, Hubei, China

    Shou-Liang Hu, Wen-Jun Gou, Qing-Feng Lei, Te-An Ma & Jun-Zhang Cheng

  2. Central Laboratory, The First Hospital of JingZhou, Yangtze University, Hubei, JingZhou, China

    Dan Wang

Authors
  1. Shou-Liang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen-Jun Gou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qing-Feng Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Te-An Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun-Zhang Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun-Zhang Cheng.

Additional information

S.-L. Hu and D. Wang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, SL., Wang, D., Gou, WJ. et al. Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis. J Nephrol 27, 111–116 (2014). https://doi.org/10.1007/s40620-014-0042-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-014-0042-7

Keywords

Search

Navigation